Moneycontrol PRO
HomeNewsBusinessMarketsAlkem Laboratories shares sink as 1.4% stake offloaded in block deal, promotor likely seller

Alkem Laboratories shares sink as 1.4% stake offloaded in block deal, promotor likely seller

Jayanti Sinha, part of the promoter group at Alkem Laboratories, is expected to sell a 1.42 percent stake via the block deal route.

June 04, 2025 / 09:20 IST
According to the March 2025 shareholding details, promoters own 55.1 percent in the firm.
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Alkem Laboratories Ltd shares sank in early trade on Wednesday, June 4, as a block deal totalling 1.4 percent of the stake in the firm took place on the bourses.

    Ahead of the block, reports suggested that Jayanti Sinha, part of the promoter group at Alkem Laboratories, is expected to divest a 1.42 percent stake in the company through a block deal today. According to the March 2025 shareholding details, Jayanti Sinha holds a 2.46 percent stake in Alkem Laboratories.

    The transaction was estimated to be worth around Rs 825 crore, and was likely to take place at a floor price of Rs 4,850 per share, which is at a 3 percent discount to the last traded price.

    At 9.20 am, shares of Alkem Labs were quoting Rs 4,973, down 0.5 percent on the NSE.

    The firm's equity structure is dominated by promoters, who own 55.1 percent in the firm. Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) own 9.4 percent and 19.4 percent stakes, respectively. Public shareholders own 16.1 percent in the firm, according to the March shareholding pattern.

    Follow our market blog to catch all the live updates

    Alkem Labs had reported a 4.2 percent on-year (YoY) rise in fourth-quarter net profit at Rs 305.9 crore, with revenue from operations growing by 7.1 percent on-year to Rs 3143.8 crore. However, the EBITDA margin contracted to 12.4 percent from 13.7 percent a year ago, which led to the disappointment among investors.

    "...we expect the EBITDA margins to remain similar as far as this financial year is concerned. Though we will get operating leverage on our basis, the growth that we will have record in the coming financial year. But we are making certain investments in R&D for certain markets where we want to expand. So that is the reason overall our EBITDA guidance in terms of percentage would be stable at 19.5 for this financial year," Vikas Gupta, CEO, Alkem Labs said during the March quarter earnings call.

    Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

    Moneycontrol News
    first published: Jun 4, 2025 08:31 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347